# Gleevec Study for Patients With Ovarian Cancer

> **NCT00510653** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 73 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Imatinib Mesylate

## Key facts

- **NCT ID:** NCT00510653
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510653, "Gleevec Study for Patients With Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00510653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*